Telehealth stocks have taken a beating this year. The takeaway for skeptical investors is that, with the pandemic ebbing, the need for telehealth will lessen. That's not necessarily the case, but that doesn't mean all telehealth companies will thrive.
Since the beginning of the year, Teladoc (NYSE: TDOC) and Doximity (NYSE: DOCS) , businesses that occupy opposite sides of the telehealth equation, have tumbled, falling more than 73% and 48%, respectively.
Telehealth isn't going away, though, because consumers, forced in some cases to use it during the pandemic, found out they liked the convenience. The J.D. Power 2022 Telehealth Satisfaction Study, released Sept. 29, showed that 94% of telehealth users say they would use it for medical services again, citing convenience and the ability to receive care quickly.
For further details see:
Which of These Bear Market Growth Stocks Is More Likely to Bounce Back?